Skip to content
S4712Senate2015-2016 SessionSame asA5453

Relates to synthetic cannabinoid

Sponsor Patty RitchieSD-48Affects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Patty Ritchie

Senator · Senate District 48

Chair, Agriculture

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A5453Assembly

Relates to synthetic cannabinoid

In Assembly Committee · Health · Sponsor William A. Barclay

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S4712

Title of bill

An act to amend the public health law and the penal law, in relation to synthetic cannabinoids

Purpose

To prohibit the sale and distribution of chemical compounds that mimic the effects of marijuana by adding it to the control substance list. It would also amend the penal law to include synthetic cannabinoids or synthetic cannabinoid analog in the definition of marijuana.

Read the full memo (743 words)

Summary of provisions

Section 1 amends § 3302 of the Public Health Law by adding two new subdivisions. New subdivision 44 defines synthetic cannabinoids as a chemical compound that is chemically synthesized. Synthetic cannabinoids are chemicals that have a binding effect on one or more cannabinoid receptors, or are a chemical isomer, salt or salt of an isomer of a compound that has demonstrated to have a binding activity at one or more cannabinoid receptors. New subdivision 45-synthetic cannabinoid analog is defined as any chemical that is substantially similar in chemical structure to a chemical compound that has been determined to have binding activity at one or ore cannabinoid receptors. This definition would not apply to any products that have been approved for medical use by the United States Food and Drug Administration.

Section 2 amends Subdivision 6 of § 220.00 of the Penal Law by adding to the definition of marijuana to include synthetic cannabinoid or synthetic cannabinoid analog.

Section 3 is the effective date.

Justification

Synthetic drugs, those that mimic the effects of banned drugs have increasing become a public safety concern throughout the country. To circumvent state and federal drug laws, the manufacturers of these synthetic drugs market their products under the guise of being a commonly used product, such as bath salts or incense. As a result, a person can purchase these items at a local convenience store, smoke shop or on the internet. News and medical community reports reveal that the users of these products were having strong psychotic effects as a result of ingesting or smoking the drug, including extreme paranoia, hallucinations, hypertension, suicidal thoughts and in some cases death.

Synthetic cannabinoids were developed by former Clemson Professor of organic chemistry, John William Huffman. Funded through the National Institute of Health, Professor Huffman and his team researched and began developing cannabinoid compounds to aid in the treatment of multiple sclerosis, AIDS and chemotherapy. His research developed over 450 synthetic cannabinoid compounds, all which mimic how "cannabinoid receptors" react when smoking or ingesting marijuana. His formula was published in the Journal of Bioorganic and Medicinal Chemistry and it

did not take long for underground chemists began creating their own compounds for sale.

There have been recent actions to combat the use of synthetic drugs. In March 2012, an Executive Order was issued banning the sale or distribution of products containing synthetic cannabinoids. The Executive Order applied a civil penalty for non-compliance by businesses. In August, the New York State Department of Health issued new regulations making it illegal to possess certain bath salts and synthetic drugs. Penalties under the new regulation include a tine up to $500 and/or a fifteen day jail sentence for those caught using or selling synthetic drugs. Additionally, in July of 2014, the Federal Government banned several popular types of synthetic marijuana and bath salts in the Food and Drug Safety and Innovation Act.

Despite these various actions taken at the federal, state and in some instances, at the local level, enforcing these bans have proven difficult due to manufacturers' ability to alter chemical compounds and circumvent the law. Shortly after the ban went into effect, it was reported that stores began selling different types of synthetic drugs not included in the list of banned products. This has become a problem for states because banning an item or putting it on the controlled substance list requires knowing the chemical compound of such item. With nearly 400 compounds or more in existence, this has created challenges for many states, including New York.

This legislation bans those products that produce the same effect on a person's cannabinoid receptors, defines synthetic cannabinoid as a controlled substance product,excludes those chemical compounds approved by the FDA and would add synthetic cannabinoids to the definition of marijuana in the Penal Law. This is a comprehensive and proactive approach to addressing this issue rather than waiting to discover a new chemical compound after it reaches the public.

Prior legislative history

2013-2014: S.5379/A.5441 2011-2012: S.6717/A8913

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.